Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: A single institution series

Haematologica

Volumn 85, Issue 8, 2000, Pages 877-878

  Ruano, D ^a   Diaz, M A ^a   Tutor, O ^a   Garcia Sanchez, F ^a   Martinez, P ^a   Madero, L ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

Childhood ALL; Minimal residual disease

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; FLUOROURACIL; METHOTREXATE; STEROID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; FEMALE; HUMAN; IMMUNOPHENOTYPING; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; PROGNOSIS; T LYMPHOCYTE;

ADOLESCENT; ANEUPLOIDY; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; BONE MARROW; CHILD; CHILD, PRESCHOOL; DAUNORUBICIN; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; GENES, IMMUNOGLOBULIN; HUMAN; IMMUNOGLOBULINS, HEAVY-CHAIN; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKOCYTE COUNT; MALE; NEOPLASM PROTEINS; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; PREDNISONE; PROGNOSIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; REMISSION INDUCTION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VINCRISTINE;

EID: 0033826771     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
2. Monoclonality in B-cell lymphoma detected in paraffin wax embedded using the polymerase chain reaction
3. Outcome prediction in childhood acute lymphoblastic leukemia by molecular quantification of residual disease at the end of induction
4. Use of polymerase chain reaction to monitor minimal residual disease in acute lymphoblastic leukemia patients
5. Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia
6. A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukemia: MRD level at the end of induction is a strong predictive factor of relapse
7. Follow-up of residual disease (MRD) in B-lineage acute leukemia using a simplified PCR strategy: Evolution of MRD rather than its detection is correlated with clinical outcome
8. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia
9. Prolonged persistence of PCR detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia
10. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer Childhood Leukemia Cooperative Group